E. Bel (Leiden, The Netherlands), L. Allegra (Milano, Italy)
Nonselective cyclo-oxygenase inhibition: effects on exhaled eicosanoids in patients with chronic obstructive pulmonary disease
P. Montuschi, G. Ciabattoni, S. A. Kharitonov, P. J. Barnes (Rome, Chieti, Italy; London, United Kingdom)
|  |
The effectiveness of nebulizer therapy in the treatment of patients with bronchial asthma
I. A. Zarembo (Saint-Petersburg, Russia)
| |
Osmolality changes in nebulizer solutions may induce bronchoconstriction in asthmatic patients
C. Terzano, L. Allegra (Rome, Italy)
| |
Inhaled furosemide & lung epithelial permeability: an added dimension to asthma therapy
U. N. Bhure, S. M. Pitale, B. M. Bhatt, S. J. Pednekar, S. A. Desai, V. V. Chari, J. M. Joshi, A. J. Paidhungat (Mumbai, India)
| |
Good tolerance of rofecoxib in aspirin-induced asthma
G. Bochenek, E. Nizankowska, F. Mejza, M. Swierczynska, A. Szczeklik (Cracow, Poland)
| |
Treating rhinitis in patients with bronchial asthma
M. L. Machado, R. C. A. Leite (Uppsala, Sweden; Sao Paulo, Brazil)
| |
Treatment of nasal polyposis in aspirine sensitive asthma
D. T. Dimitrievska, M. M. Zdraveska, A. S. Gjorcev, D. L. Todevski, T. T. Stefanovski (Skopje, Macedonia)
| |
Emergency calls, near fatal and fatal asthma: a 10-years retrospective study
B. Kral, J. Gregor, V. Cerny, P. Hottmar, M. Resl, J. Stetina (Hradec Kralove, Czech Republic)
| |
Prescription rates for various classes of COPD & asthma medication in Turkey
A. Utkusavas, C. Cuhadaroglu, M. Erelel, E. Kiyan, O. Arseven, Z. Kilicaslan, F. K. Erkan, T. Ece, L. Tabak (Istanbul, Turkey)
| |
Epinastine improves cough in eosinophilic bronchitis (atopic cough)
T. Shioya, M. Sano, M. Kagaya, K. Sato, M. Kashima, N. Izumiyama, S. Miura, M. Sasaki, M. Miura (Akita, Japan)
| |
Formoterol via turbuhaler (F) versus salbutamol via pressurized metered-dose inhaler (SB) in acute exacerbations of COPD
M. Cazzola, M. D'Amato, F. Di Perna, F. Calderaro, C. Califano, M. G. Matera, G. D'Amato (Naples, Italy)
| |
Three month treatment with formoterol in mild asthma: efficacy and side effects
A. D. Barela, J. Wronska, A. Safianowska, R. Chazan (Warsaw, Poland)
| |
Efficacy of long-term formoterol therapy vs as-needed salbutamol use in patients with moderate asthma
M. I. Boskovska, B. D. Gerovski, T. M. Dimitrovski, S. D. Arbutina, B. M. Jovkovska Kaeva (Skopje, Macedonia)
| |
The combination salmeterol (S) + fluticasone propionate (F) in mild-to-moderate asthma
R. W. Dal Negro, C. Micheletto, C. Pomari, F. Trevisan, S. Tognella (Bussolengo, Italy)
| |
Salmeterol or ipratropium bromide/fenoterol in stable mild-to-moderate COPD
N. Dauletbaev, K. Viel, J. Bargon (Frankfurt, Munich, Germany)
| |
The comparison of ipratropium bromide in parallel group study in adults with chronic obstructive pulmonary disease (COPD) and gastroduodenal ulcer
A. A. Vizel, K. A. Habibullin, R. T. Habibullina, R. T. Miftachutdinova (Kazan, Russia)
| |
Influence of basal FEV1 on the response to bronchodilator agents in COPD
B. Chenuel, G. Kneizeh, C. Moreau-Colson, P. Haouzi (Vandoeuvre-lès-Nancy, France)
| |
Tremormetry with a laser pointer; normal values and reproducibility
T. Nizet, M. Broeders, H. Folgering (Groesbeek, The Netherlands)
| |
Ease of use by patients is a key element in determining physician and nurse preference of inhaler devices for asthma treatment
D. Ryan, K. Nolop (Loughborough, United Kingdom; Kenilworth, United States Of America)
| |